Legislation Supported By Senators Collins, King to Combat Rising Prescription Drug Prices Signed into Law

Washington, D.C. — U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) announced that legislation they cosponsored to combat anticompetitive practices used by some brand-name drug companies to block entry of lower-cost generic drugs has been signed into law.  The Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act will deter pharmaceutical companies from blocking cheaper generic alternatives from entering the marketplace.  The CREATES Act was included as part of the final appropriations package.



Senator Collins Announces Historic Funding Increases for Alzheimer’s, Diabetes, and Other Biomedical Research

Washington, D.C.—U.S. Senator Susan Collins announced that the Senate approved a $2.6 billion increase for the National Institutes of Health (NIH)—bringing total funding for the NIH to $41.7 billion—as part of the appropriations package.  The legislation is expected to be signed into law by the President this evening.


As a senior member of the Appropriations Committee and the Chairman of the Aging Committee, Senator Collins is a champion for greater investments in biomedical research. 



Senate Passes Collins, King Bill to Improve Broadband Data Maps

WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King, co-chair of the Senate Rural Broadband Caucus, lauded the passage of the Broadband Deployment Accuracy and Technological Availability (DATA) Act, a bipartisan bill they co-sponsored. The legislation would increase the accuracy of the Federal Communications Commission’s (FCC) broadband availability maps by improving the process by which broadband data is collected.